Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
deals
fda
investing
4
×
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
national
national top stories
startups
biotech ipos
cancer
crispr-cas9
detroit blog main
detroit top stories
eidos therapeutics
europe blog main
europe top stories
incyte
indiana blog main
indiana top stories
kidney disease
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
shattuck labs
What
days
4
×
biotech
roundup
ahead
alliance
ambien
american
annual
arrival
asco
attendees
attention
babies
bio
birth
born
breastfeed
bristol
buy
calls
camp’s
cancer
cash
changing
chicago
city
clinical
color
combinations
community’s
companies
crispr
drug
expanding
focus
giving
growing
gut
hasn’t
home
Language
unset
Current search:
investing
×
days
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
